SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY)

被引:0
|
作者
Tedeschi, A. [1 ]
Trotman, J. [2 ,3 ]
Zinzani, P. [4 ]
Cavallo, F. [5 ]
Marasca, R. [6 ]
Liberati, A. [7 ]
Linton, K. [8 ]
Mckay, P. [9 ]
Hu, B. [10 ]
Coleman, M. [11 ]
Ardeshna, K. [12 ,13 ]
Bijou, F. [14 ]
Marcus, R. [15 ]
Portell, C. [16 ]
Thieblemont, C. [17 ]
Bachy, E. [18 ]
Costello, R. [19 ]
Iyengar, S. [20 ]
Mocikova, H. [21 ]
Co, M. [22 ,23 ]
Li, X. [22 ,23 ]
Zhou, W. [22 ,23 ]
Cappellini, M. [22 ,23 ]
Tankersley, C. [22 ,23 ]
Huang, J. [22 ,23 ]
Opat, S. [24 ,25 ]
机构
[1] ASST Grande Osped Metropolitano Niguarda, Milan, Italy
[2] Concord Repatriat Gen Hosp, Concord, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Univ Bologna, Inst Hematol Serognoli, Bologna, Italy
[5] Azienda Osped Citto Salute & Sci Torino, Turin, Italy
[6] AOU Policlin Modena, Modena, Italy
[7] Azienda Osped Santa Maria Terni, Terni, Italy
[8] The Christie, Manchester, Lancs, England
[9] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[10] Levine Canc Inst Atrium Hlth, Charlotte, NC USA
[11] Clin Res Alliance, New Hyde Pk, NY USA
[12] Univ Coll London NHS Fdn Trust, Dept Haematol, London, England
[13] UCLH NIHR Biomed Res Ctr, London, England
[14] Inst Bergonie, Bordeaux, France
[15] Sarah Cannon Res Inst UK, London, England
[16] Univ Virginia Hlth Syst, Charlottesville, VA USA
[17] Paris Univ Diderot, Hop St Louis, APHP, Hematooncol, Paris, France
[18] Ctr Hosp Lyon Sud, Pierre Benite, France
[19] Hop Conception APHM, Marseille, France
[20] Royal Marsden Hosp, London, England
[21] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic
[22] BeiGene BeifingCo Ltd, Beijing, Peoples R China
[23] BeiGene USA Inc, Cambridge, MA USA
[24] Monash Hlth, Clayton, Vic, Australia
[25] Monash Univ, Clin Haematol Unit, Clayton, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C044
引用
收藏
页码:35 / 35
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
    Opat, Stephen
    Tedeschi, Alessandra
    Hu, Bei
    Linton, Kim M.
    Mckay, Pamela
    Leitch, Sophie
    Coleman, Morton
    Zinzani, Pier Luigi
    Jin, Jie
    Sun, Mingyuan
    Sobieraj-Teague, Magdalena
    Browett, Peter
    Ke, Xiaoyan
    Thieblemont, Catherine
    Ardeshna, Kirit
    Bijou, Fontanet
    Walker, Patricia
    Hawkes, Eliza A.
    Ho, Shir-Jing
    Zhou, Keshu
    Liang, Zhiyu
    Xu, Jianfeng
    Tankersley, Chris
    Delarue, Richard
    Co, Melannie
    Trotman, Judith
    BLOOD ADVANCES, 2023, 7 (22) : 6801 - 6811
  • [3] Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial
    Opat, Stephen
    Tedeschi, Alessandra
    Linton, Kim
    McKay, Pamela
    Hu, Bei
    Chan, Henry
    Jin, Jie
    Zinzani, Pier Luigi
    Browett, Peter
    Coleman, Morton
    Sobieraj-Teague, Magdalena
    Ke, Xiaoyan
    Sun, Mingyuan
    Marcus, Robert
    Portell, Craig A.
    Zhou, Keshu
    Thieblemont, Catherine
    Co, Melannie
    Wang, Weige
    Tankersley, Chris
    Zhou, Wenxiao
    Cappellini, Massimo
    Huang, Jane
    Trotman, Judith
    BLOOD, 2020, 136
  • [4] Phase 2 Study of Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Marginal Zone Lymphoma
    Opat, Stephen
    Marcus, Robert
    Portell, Craig A.
    Reed, William
    Tankersley, Chris
    Huang, Jane
    Trotman, Judith
    BLOOD, 2019, 134
  • [5] The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma
    Opat, Stephen
    Tedeschi, Alessandra
    Linton, Kim
    McKay, Pamela
    Hu, Bei
    Chan, Henry
    Jin, Jie
    Sobieraj-Teague, Magdalena
    Zinzani, Pier Luigi
    Coleman, Morton
    Thieblemont, Catherine
    Browett, Peter
    Ke, Xiaoyan
    Sun, Mingyuan
    Marcus, Robert
    Portell, Craig A.
    Ardeshna, Kirit
    Bijou, Fontanet
    Walker, Patricia
    Hawkes, Eliza A.
    Mapp, Sally
    Ho, Shir-Jing
    Talaulikar, Dipti
    Zhou, Ke-Shu
    Co, Melannie
    Li, Xiaotong
    Zhou, Wenxiao
    Cappellini, Massimo
    Tankersley, Chris
    Huang, Jane
    Trotman, Judith
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6323 - 6332
  • [6] Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
    Panayiotidis, Panayiotis
    Follows, George A.
    Mollica, Luigina
    Nagler, Arnon
    Ozcan, Muhit
    Santoro, Armando
    Stevens, Don
    Trevarthen, David
    Hiemeyer, Florian
    Garcia-Vargas, Jose
    Childs, Barrett H.
    Zinzani, Pier Luigi
    Dreyling, Martin
    BLOOD ADVANCES, 2021, 5 (03) : 823 - 828
  • [7] Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): Final analysis of MAGNOLIA (BGB-3111-214)
    Linton, Kim M.
    Trotman, Judith
    Mckay, Pamela
    Ardeshna, Kirit
    Iyengar, Sunil
    Tedeschi, Alessandra
    Hu, Bei
    Leitch, Sophie
    Jin, Jie
    Sun, Mingyuan
    Sobieraj-Teague, Magdalena
    Zinzani, Pier Luigi
    Browett, Peter
    Ke, Xiaoyan
    Portell, Craig A.
    Thieblemont, Catherine
    Bijou, Fontanet
    Walker, Patricia
    Hawkes, Eliza A.
    Ho, Shir-Jing
    Zhou, Keshu
    Liang, Zhiyu
    Xu, Jianfeng
    Tankersley, Chris
    Delarue, Richard
    Co, Melannie
    Opat, Stephen
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 12 - 12
  • [8] Phase 2 study of zanubrutinib (BGB-3111) in patients with relapsed/refractory marginal zone lymphoma (R/R MZL).
    Opat, Stephen
    Marcus, Robert
    Portell, Craig Anthony
    Reed, William
    Co, Melannie
    Huang, Jane
    Trotman, Judith
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
    Phillips, Tycel J.
    Corradini, Paolo
    Gurion, Ronit
    Patti, Caterina
    Tani, Monica
    Avigdor, Abraham
    Jurczak, Wojciech
    Mehta, Amitkumar
    Zinzani, Pier Luigi
    Lossos, Izidore S.
    Thieblemont, Catherine
    Zheng, Fred
    Rappold, Erica
    Zhao, Wanying
    Johnson, Peter
    BLOOD, 2020, 136
  • [10] Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial
    Opat, Stephen
    Tedeschi, Alessandra
    Hu, Bei
    Linton, Kim M.
    McKay, Pamela
    Chan, Henry
    Jin, Jie
    Sun, Mingyuan
    Sobieraj-Teague, Magdalena
    Zinzani, Pier Luigi
    Browett, Peter J.
    Ke, Xiaoyan
    Portell, Craig A.
    Thieblemont, Catherine
    Ardeshna, Kirit
    Bijou, Fontanet
    Walker, Patricia
    Hawkes, Eliza
    Ho, Shir-Jing
    Zhou, Keshu
    Liang, Zhiyu
    Xu, Jianfeng
    Tankersley, Chris
    Delarue, Richard
    Co, Melannie
    Trotman, Judith
    BLOOD, 2022, 140